Constructing a prognostic model for colon cancer patients on basis of coagulation genes enriched in cancer-associated fibroblasts to guide personalized immunotherapy
Open Access
- 9 August 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 26 (5) , 845-860
Abstract
Objectives: Colon cancer is a global health challenge. This research is designed to build a prognostic model that can personalize the guidance of immunotherapy among colon cancer patients. Methods: Coagulation-associated prognostic genes which were subsequently integrated into a Least Absolute Shrinkage and Selection Operator algorithm for constructing a prognostic model were identified with the univariate Cox analyses. The potential of coagulation-related risk score (CRRS) in prognosis and immunotherapy outcomes was rigorously assessed. Finally, the cellular origin of genes in the CRRS model was explored with single-cell RNA-seq data, and the biological functions of core genes were further confirmed by cell function experiments. Results: Our findings showed the CRRS model usefully classified patients into high-risk and low-risk groups. High-risk patients exhibited worse total survival. A nomogram was subsequently devised, enabling quantitative survival prediction by incorporating CRRS, age, sex, and TNM stage. Moreover, the CRRS model predicted the extent of cancer-associated fibroblasts (CAFs) infiltration. The analysis further indicated diminished immune responsiveness in high-risk patients, and single-cell data analysis pinpointed TIMP1+ CAF as a potential contributor to cancer progression. Conclusions: The CRRS model can be adopted as a prognostic device for colon cancer patients and low-risk patients are more suitable for treatment with immune checkpoint inhibitors. TIMP1 secreted by CAF can promote the malignant progression of colon cancer.Keywords
Funding Information
- Key Project of Science and Technology Development of Nanjing Medicine (ZKX21042)
- The research project of jiangsu health development research center (JSHD2022057)
- Jiangsu Provincial Medical Key Discipline Cultivation Unit (JSDW202239)
- Natural Science Foundation of Jiangsu Province (BK20210031)
This publication has 41 references indexed in Scilit:
- Metastatic colorectal cancer: mechanisms and emerging therapeuticsTrends in Pharmacological Sciences, 2023
- Coagulome and the tumor microenvironment: an actionable interplayTrends in Cancer, 2022
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerCancer Cell, 2021
- Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stromaBritish Journal of Cancer, 2020
- Colorectal cancerThe Lancet, 2019
- Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients2019
- Integrating single-cell transcriptomic data across different conditions, technologies, and speciesNature Biotechnology, 2018
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadeCell Reports, 2017
- Venous thromboembolism and occult cancer: impact on clinical practiceThrombosis Research, 2016
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013